electroCore (ECOR) Return on Capital Employed (2018 - 2026)
electroCore's (ECOR) quarterly Return on Capital Employed came in at 307.61% in Q1 2026, down 19093.0% year-on-year from N/an in Q1 2025, and down 103.27% quarter-over-quarter from 151.33% in Q4 2025.
electroCore (ECOR) Return on Capital Employed (2018 - 2026) Analysis & Trends
electroCore's Return on Capital Employed history runs 9 years deep, the most recent figure standing at 307.61% for Q1 2026.
- On a quarterly basis, Return on Capital Employed fell 19093.0% year-over-year to 307.61% in Q1 2026; TTM through Mar 2026 was 307.61%, a 19093.0% decrease from a year earlier, with the FY2025 full-year figure at 159.99%, down 2685.0% from the prior year.
- Return on Capital Employed slipped to 307.61% in Q1 2026 per ECOR's latest filing, from 151.33% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 57.3% in Q1 2022 and bottomed at 307.61% in Q1 2026.
- The 5-year median for Return on Capital Employed is 149.81% (2023), against an average of 162.08%.
- Across the five-year window, Return on Capital Employed soared 15057 bps in 2024 and tumbled 19093 bps in 2026, its largest moves.
- Year by year, Return on Capital Employed stood at 113.92% in 2022, then slumped by 69 bps to 193.04% in 2023, then soared by 46 bps to 104.79% in 2024, then sank by 44 bps to 151.33% in 2025, then plunged by 103 bps to 307.61% in 2026.
- Per Business Quant, the three latest ECOR Return on Capital Employed figures stand at 307.61% (Q1 2026), 151.33% (Q4 2025), and 227.27% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | electroCore | 56,941.08 | -8.77 Mn | 8.36 Mn | -307.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -307.61% |
| Dec 31, 2025 | -151.33% |
| Sep 30, 2025 | -227.27% |
| Jun 30, 2025 | -229.67% |
| Mar 31, 2025 | -116.68% |
| Dec 31, 2024 | -104.79% |
| Sep 30, 2024 | -94.64% |
| Jun 30, 2024 | -133.61% |
| Mar 31, 2024 | -236.03% |
| Dec 31, 2023 | -193.04% |
| Sep 30, 2023 | -245.21% |
| Jun 30, 2023 | -233.93% |
| Mar 31, 2023 | -149.81% |
| Dec 31, 2022 | -113.92% |
| Sep 30, 2022 | -90.28% |
| Jun 30, 2022 | -70.26% |
| Mar 31, 2022 | -57.30% |
| Dec 31, 2021 | -50.46% |
| Sep 30, 2021 | -62.01% |
| Jun 30, 2021 | -79.94% |